Author

Paul J. Vandeventer

Baylor College of MedicineORCID 0000-0002-9795-7647Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Paul J. Vandeventer1 paper

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Chad A. ShawiD· 2 shared Amy L. McGuireiD· 1 shared Briana A. BurnsiD· 1 shared Donna Marie MuznyiD· 1 shared Emily J. HilliD· 1 shared Emily Schulman· 1 shared HarshaVardhan DoddapaneniiD· 1 shared Hiba Saade· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Chad A. ShawORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genome sequencing in the Parkinson disease clinic

Emily J. Hill, Laurie A. Robak, Rami Al‐Ouran, Jennifer Deger, Jamie C Fong, Paul J. Vandeventer, Emily Schulman, Sindhu Rao, Hiba Saade, Joseph M. Savitt, Rainer von Coelln, Neeja Desai, HarshaVardhan Doddapaneni, Sejal Salvi, Shannon Dugan, , Joshua M Shulman

This study performs genome sequencing in Parkinson's disease patients and finds genetic variants in 3.4% for LRRK2 and 10.1% for GBA, with 82% of patients willing to share variants with relatives.

Neurology Genetics · Jun 20, 2022Peer-reviewedGenetic & Genomic Medicine

Selection for or against Escape from Nonsense Mediated Decay is a Novel Signature for the Detection of Cancer Genes

Runjun D. Kumar, Briana A. Burns, Paul J. Vandeventer, Pamela N. Luna, Chad A. Shaw

The paper identifies cancer genes by analyzing NMD escape bias in somatic mutations from The Cancer Genome Atlas, finding 29 genes with significant NMD- rates.

Cancer Genetics · Sep 23, 2021Peer-reviewedGenomics